Related references
Note: Only part of the references are listed.ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
John Alec Moral et al.
NATURE (2020)
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8(+) T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy
Marianne Weulersse et al.
IMMUNITY (2020)
The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity
Sanjivan Gautam et al.
NATURE IMMUNOLOGY (2019)
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
Clemence Hollande et al.
NATURE IMMUNOLOGY (2019)
TOX is a critical regulator of tumour-specific T cell differentiation
Andrew C. Scott et al.
NATURE (2019)
The Transcription Factor Bhlhe40 Programs Mitochondria! Regulation of Resident CD8+ T Cell Fitness and Functionality
Chaofan Li et al.
IMMUNITY (2019)
Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells
Sema Kurtulus et al.
IMMUNITY (2019)
The First Shall (Be) Last: Understanding Durable T Cell Responses in Immunotherapy
Daniela S. Thommen
IMMUNITY (2019)
Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
Imran Siddiqui et al.
IMMUNITY (2019)
Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours (vol 552, pg 253, 2017)
J. Justin Milner et al.
NATURE (2018)
Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
Xinyi Guo et al.
NATURE MEDICINE (2018)
Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma
Min Yang et al.
PLOS ONE (2018)
High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells
Jing Li et al.
FRONTIERS IN IMMUNOLOGY (2018)
Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer
Donye Dominguez et al.
JOURNAL OF IMMUNOLOGY (2017)
Transcription Factor IRF4 Promotes CD8+ T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic Infection
Kevin Man et al.
IMMUNITY (2017)
Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy
Binfeng Lu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection
Ran He et al.
NATURE (2016)
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Se Jin Im et al.
NATURE (2016)
CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles
Yew Ann Leong et al.
NATURE IMMUNOLOGY (2016)
Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes
Laura K. Mackay et al.
SCIENCE (2016)
The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness
Tuoqi Wu et al.
SCIENCE IMMUNOLOGY (2016)
T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate
Laura K. Mackay et al.
IMMUNITY (2015)
Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+ T and NK Cells
Xin Gao et al.
JOURNAL OF IMMUNOLOGY (2015)
T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells
Gang Li et al.
PLOS ONE (2013)
Network Analysis Reveals Centrally Connected Genes and Pathways Involved in CD8+ T Cell Exhaustion versus Memory
Travis A. Doering et al.
IMMUNITY (2012)
TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
Xin Gao et al.
PLOS ONE (2012)
Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection
Michael A. Paley et al.
SCIENCE (2012)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses
Yibei Zhu et al.
JOURNAL OF IMMUNOLOGY (2010)
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
Luca Gattinoni et al.
NATURE MEDICINE (2009)
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?
Christine Moussion et al.
PLOS ONE (2008)
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
AM Intlekofer et al.
NATURE IMMUNOLOGY (2005)
TGF-β-dependent CD103 expression by CD8+ T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease
R El-Asady et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Control of effector CD8+ T cell function by the transcription factor Eomesodermin
EL Pearce et al.
SCIENCE (2003)
Share Paper
